BioCurex, Inc.(fka BOCX)

[JAZZ ONE]

Interview:

I just listened to Dr. Whittenberg's interview. I'm a little surprised no one is talking about this or offering an opinion.

He makes some very interesting and forward looking statements about the Abbott deal and anticipated revenues such as:

"we expect revenues in the first couple of years to be in the 10's of millions with no further expense o our part. Abbott has already validated the tecnology and it only a matter of time before they market it. It is no longer a question of if but when. It will happen. Listing on a new board has been frustrating but we expect that to happen and it will not be the last listing as the stock increases in value we should be listed higher. Competition among other major pharms to use this technology will be fierce in order to be first to 'come to market'.

Sounds pretty good to me.

Listen if you have not done so already.